These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18281290)

  • 1. A novel ABCC8 (SUR1)-dependent mechanism of metabolism-excitation uncoupling.
    Babenko AP
    J Biol Chem; 2008 Apr; 283(14):8778-82. PubMed ID: 18281290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
    N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.
    de Wet H; Rees MG; Shimomura K; Aittoniemi J; Patch AM; Flanagan SE; Ellard S; Hattersley AT; Sansom MS; Ashcroft FM
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18988-92. PubMed ID: 18025464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
    Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
    Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic K(ATP) channels cause neonatal diabetes by perturbing the coupling between Kir6.2 and SUR1 subunits.
    Lin YW; Akrouh A; Hsu Y; Hughes N; Nichols CG; De León DD
    Channels (Austin); 2012; 6(2):133-8. PubMed ID: 22562119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
    Tammaro P; Ashcroft F
    J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
    Chan KW; Wheeler A; Csanády L
    J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.
    Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL
    J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
    Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
    J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tolbutamide site of SUR1 and a mechanism for its functional coupling to K(ATP) channel closure.
    Babenko AP; Gonzalez G; Bryan J
    FEBS Lett; 1999 Oct; 459(3):367-76. PubMed ID: 10526167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.
    Tarasov AI; Nicolson TJ; Riveline JP; Taneja TK; Baldwin SA; Baldwin JM; Charpentier G; Gautier JF; Froguel P; Vaxillaire M; Rutter GA
    Diabetes; 2008 Jun; 57(6):1595-604. PubMed ID: 18346985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
    Masia R; Enkvetchakul D; Nichols CG
    J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels.
    Yan FF; Lin CW; Cartier EA; Shyng SL
    Am J Physiol Cell Physiol; 2005 Nov; 289(5):C1351-9. PubMed ID: 15987767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
    Girard CA; Shimomura K; Proks P; Absalom N; Castano L; Perez de Nanclares G; Ashcroft FM
    Pflugers Arch; 2006 Dec; 453(3):323-32. PubMed ID: 17021801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.
    Proks P; Girard C; Ashcroft FM
    Hum Mol Genet; 2005 Sep; 14(18):2717-26. PubMed ID: 16087682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
    Huopio H; Vauhkonen I; Komulainen J; Niskanen L; Otonkoski T; Laakso M
    Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An abundant, truncated human sulfonylurea receptor 1 splice variant has prodiabetic properties and impairs sulfonylurea action.
    Schmid D; Stolzlechner M; Sorgner A; Bentele C; Assinger A; Chiba P; Moeslinger T
    Cell Mol Life Sci; 2012 Jan; 69(1):129-48. PubMed ID: 21671119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes in very young children and mutations in the insulin-secreting cell potassium channel genes: therapeutic consequences.
    Flechtner I; Vaxillaire M; Cavé H; Scharfmann R; Froguel P; Polak M
    Endocr Dev; 2007; 12():86-98. PubMed ID: 17923772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
    Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
    Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
    Pearson ER; Flechtner I; Njølstad PR; Malecki MT; Flanagan SE; Larkin B; Ashcroft FM; Klimes I; Codner E; Iotova V; Slingerland AS; Shield J; Robert JJ; Holst JJ; Clark PM; Ellard S; Søvik O; Polak M; Hattersley AT;
    N Engl J Med; 2006 Aug; 355(5):467-77. PubMed ID: 16885550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.